Treatments for advanced laryngeal cancer

Last medical review:

You may be offered the following treatments for advanced (stage 4) laryngeal cancer. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.

Chemoradiation

Radiation therapy uses high-energy rays or particles to destroy cancer cells. Chemotherapy uses drugs to destroy cancer cells. Radiation therapy combined with chemotherapy (called chemoradiation) is a standard treatment for advanced laryngeal cancer that has spread (metastasized) to other parts of the body.

If you canʼt tolerate chemoradiation because of the side effects or other health issues, you may have radiation therapy or chemotherapy on its own or after surgery.

Find out more about radiation therapy and chemotherapy for laryngeal cancer.

Surgery

You may be offered surgery for advanced laryngeal cancer.

The type of surgery you have will depend on where the cancer is in the larynx (voice box). If cancer is above the vocal cords (supraglottic carcinoma) or in the vocal cords (glottic carcinoma), surgery may include:

  • endoscopic laser surgery to remove the tumour
  • laryngectomy to remove all or part of the larynx
  • surgery to remove lymph nodes in the neck

If cancer is below the vocal cords (subglottic carcinoma), surgery may include a laryngectomy and removal of the thyroid (called a thyroidectomy) and lymph nodes in the neck.

Find out more about surgery for laryngeal cancer.

Radiation therapy

Radiation therapy uses high-energy rays or particles to destroy cancer cells. Radiation therapy may be used to destroy cancer cells left behind after surgery (called adjuvant therapy).

Find out more about radiation therapy for laryngeal cancer.

Immunotherapy

Immunotherapy helps to strengthen or restore the immune system’s ability to fight cancer. Immunotherapy may be used to treat advanced supraglottic carcinoma.

Pembrolizumab (Keytruda) may be used as a first-line therapy. It is sometimes offered with chemotherapy.

Nivolumab (Opdivo) may be used if the cancer has stopped responding to chemotherapy with platinum drugs such as cisplatin or carboplatin.

Find out more about immunotherapy for laryngeal cancer.

Targeted therapy

Targeted therapy uses drugs to target specific molecules (such as proteins) on cancer cells or inside them to stop the growth and spread of cancer. Targeted therapy may be used to treat advanced cancer in the supraglottis.

Cetuximab (Erbitux) may be used with radiation therapy. It's offered if you canʼt tolerate chemotherapy with platinum drugs such as cisplatin or carboplatin.

Find out more about targeted therapy for laryngeal cancer.

Clinical trials

Talk to your doctor about clinical trials open to people with laryngeal cancer in Canada. Clinical trials look at new ways to prevent, find and treat cancer.

Find out more about clinical trials.

Expert review and references

  • Harold Lau, MD, FRCPC

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society